Abstract
Objectives-To investigate change in psychiatric disorder and change in cognitive function in patients with systemic lupus erythematosus (SLE) assessed on two occasions two years apart.
Methods-A prospective cohort study of 49 The present study investigates this hypothesis by comparing change in psychiatric disorder over two years with change in cognitive function, to determine whether the resolution of psychiatric disorder is associated with improvement of cognitive function.
Patients and methods

STUDY DESIGN
This was a two year prospective study.
STUDY POPULATION
The study subjects were derived from a group of 73 patients with SLE, described in detail elsewhere.' Briefly, they were Losses to follow up Of the 73 patients in the original study, there were 24 patients who did not attend for a second psychiatric assessment. The reasons were death (four, including one suicide), leaving the area (three), declined to attend on the second occasion (1 7): 49 patients were assessed twice. Eleven of these 49 patients did not complete cognitive assessments at both first and second interview: 38 patients had cognitive testing twice.
Patients lost to follow up did not differ significantly from those included in the current study with respect to age, duration of SLE, total social stress and support scores, activity of SLE, degree of cognitive impairment or presence of psychiatric disorder at the first interview. Of the 15 patients with a psychiatric disorder at the first interview, 10 were followed up (67%), compared with 39 of 56 without an initial psychiatric disorder (70%). Four patients died during the study period, including one suicide-a male with profound cognitive impairment, recent stroke and depression. The causes of death in the other patients were: stroke (one patient who also had depression and cognitive impairment), and multi-system SLE with predominantly renal (one patient) and cardiovascular (one patient) involvement. These last two patients did not have a psychiatric disorder or cognitive impairment at the initial assessment. The four patients who died had a higher prevalence of clinical manifestations at the initial assessment, indicating more severe SLE.
Psychiatric disorder Psychiatric disorder (ID > 5) was present in 12/49 (24-5%) patients at the second interview (eight depression and four anxiety) compared with 10/49 (20%) at the first interview. Five further patients with psychiatric disorder at first interview were lost to follow up (two had died, including one suicide, two had moved away and one declined to attend).
The numbers of patients with psychiatric disorder at initial or follow up interview are shown in table 1 . Case, case = psychiatric disorder present at both first and second interview; case, non-case = psychiatric disorder present atfirst interview but not at second; noncase, non-case = no psychiatric disorder atfirst or second interview; case, non-case = psychiatric disorder present at second interview, but not atfirst. of the presence of psychiatric disorder (fig 3) . Disease activity (BILAG score and laboratory data) was also similar for the four groups (data not shown). Social stress and lack of support scores Total stress scores increased significantly in the eight 
Discussion
We have demonstrated considerable change in the psychiatric and cognitive status of patients with SLE over two years. Change in cognitive function appeared to mirror change in psychiatric status.
Subclinical CNS involvement in SLE, which may lead to overt cerebral disorder such as dementia, stroke or epilepsy, is an extremely worrying possibility for patients and clinicians. We previously reported a point prevalance of cognitive impairment of 26%,' which is similar to the 21% reported by Hanly et al in another cross-sectional study, although much lower than that found by other workers who employed more detailed tests, and used a lower threshold for defining abnormality.2 The retrospective or cross-sectional design of most previous studies,'-5 however, has meant they have not been able to investigate change in cognitive impairment over time to establish whether it is always a progressive, relentless process. Furthermore, they have not established whether poor performance on cognitive testing performed at a single point in time predicts future CNS events.
In this prospective study, we found no evidence of progressive cognitive impairment amongst patients who were assessed at two points, two years apart. Indeed, most patients who had cognitive impairment at the first assessment had improved by the time of the second assessment: only one of the 10 patients with SLE for one year and also found that cognitive impairment resolved in the majority, but no comparison between cognitive impairment and psychiatric status was made in that study.
As expected, there was a significant increase in the prevalence of clinical features over two years, indicating progression of the disease process. There was a lack of association between change in psychiatric status and change in disease activity, severity, or corticosteroid medication. By contrast, there were highly significant associations between change in psychiatric disorder and change in social stress and lack of support scores, thus supporting previous reports proposing that psychiatric disorder in SLE is more closely associated with concurrent psychological stresses than with the course of a painful debilitating illness. ' 22 The principal limitation of this study was the reduced number of patients who were able to complete psychiatric and cognitive assessments on both occasions. Forty nine patients from the original cohort of 73 completed both psychiatric assessments but, of these, only 38 completed both cognitive assessments. Most of the losses to follow up declined a second psychological assessment. Those reviewed were similar to the patients lost to follow up for all variables recorded, hence our findings can be generalised to other similar groups of lupus patients. To avoid potential bias resulting from patients lost to follow up we used paired analyses restricted to the 49 patients on whom we had complete psychiatric and clinical data, or the 38 on whom we had complete cognitive data where appropriate. Despite small numbers our study yielded clear results which can be considered valid.
Psychiatric disorder is common in SLE and is independently associated with social stress 22 and two indicators of cognitive function.' The present study extends these findings by showing that cognitive function returns to normal when psychiatric disorder resolves, in patients with SLE followed for two years. They indicate, once again, the importance of detecting and treating psychiatric disorder in patients with SLE. 
